Literature DB >> 16998891

Characterization of thromboxane A2 receptor signaling in developing rat oligodendrocytes: nuclear receptor localization and stimulation of myelin basic protein expression.

Santosh Ramamurthy1, Fozia Mir, Robert M Gould, Guy C Le Breton.   

Abstract

The present work investigates the role of thromboxane A(2) (TXA(2)) receptors in the development of oligodendrocytes (OLGs). The results demonstrate that the proteins of the TXA(2) signaling pathway, i.e., cyclooxygenase (COX-1), TXA(2) synthase (TS), and TXA(2) receptor (TPR) are expressed in the developing rat brain during myelination. Furthermore, culture of OLG progenitor cells (OPCs) revealed that the expression levels of these proteins as well as TXA(2) synthesis increase during OLG maturation. Separate studies established that activation of TPRs by the agonist U46619 increases intracellular calcium in both OPCs and OLGs as visualized by digital fluorescence imaging. Immunocytochemical staining demonstrated that TPRs are localized in the plasma membrane and perinuclear compartments in OPCs. However, during OLG differentiation, TPRs shift their localization pattern and also become associated with the nuclear compartment. This shift to nuclear localization was confirmed by biochemical analysis in cultured cells and by immunocytochemical analysis in developing rat brain. Finally, it was found that U46619 activation of TPRs in maturing OLGs resulted in enhanced myelin basic protein (MBP) expression. Alternatively, inhibition of endogenous TPR signaling led to reduced MBP expression. Furthermore, TPR-mediated MBP expression was found to be associated with increased transcription from the MBP promoter using a MBP-luciferase reporter. Collectively, these findings suggest a novel TPR signaling pathway in OLGs and a potential role for this signaling during OLG maturation and myelin production.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16998891     DOI: 10.1002/jnr.21061

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  A novel nuclear signaling pathway for thromboxane A2 receptors in oligodendrocytes: evidence for signaling compartmentalization during differentiation.

Authors:  Fozia Mir; Guy C Le Breton
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

2.  G alpha12 is targeted to the mitochondria and affects mitochondrial morphology and motility.

Authors:  Alexandra V Andreeva; Mikhail A Kutuzov; Tatyana A Voyno-Yasenetskaya
Journal:  FASEB J       Date:  2008-03-26       Impact factor: 5.191

3.  Intracrine endothelin signaling evokes IP3-dependent increases in nucleoplasmic Ca²⁺ in adult cardiac myocytes.

Authors:  Clémence Merlen; Nada Farhat; Xiaoyan Luo; David Chatenet; Artavazd Tadevosyan; Louis R Villeneuve; Marc-Antoine Gillis; Stanley Nattel; Eric Thorin; Alain Fournier; Bruce G Allen
Journal:  J Mol Cell Cardiol       Date:  2013-06-10       Impact factor: 5.000

4.  Temporal changes of cytochrome P450 (Cyp) and eicosanoid-related gene expression in the rat brain after traumatic brain injury.

Authors:  Matthew Birnie; Ryan Morrison; Ramatoulie Camara; Kenneth I Strauss
Journal:  BMC Genomics       Date:  2013-05-04       Impact factor: 3.969

Review 5.  Intracellular Protein Shuttling: A Mechanism Relevant for Myelin Repair in Multiple Sclerosis?

Authors:  Peter Göttle; Patrick Küry
Journal:  Int J Mol Sci       Date:  2015-07-03       Impact factor: 5.923

6.  Thromboxane A2 Receptor Stimulation Enhances Microglial Interleukin-1β and NO Biosynthesis Mediated by the Activation of ERK Pathway.

Authors:  Wanlin Yang; Aijuan Yan; Tingting Zhang; Jiaxiang Shao; Tengyuan Liu; Xiao Yang; Weiliang Xia; Yi Fu
Journal:  Front Aging Neurosci       Date:  2016-01-29       Impact factor: 5.750

7.  Upregulation of Myelin Gene Expression by a Physically-Modified Saline via Phosphatidylinositol 3-Kinase-Mediated Activation of CREB: Implications for Multiple Sclerosis.

Authors:  Malabendu Jana; Supurna Ghosh; Kalipada Pahan
Journal:  Neurochem Res       Date:  2017-11-15       Impact factor: 3.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.